Table 2 Clinical endpoints
From: A pilot study of Bifidobacterium breve in neonates undergoing surgery for congenital heart disease
Group A | Group B | p value | |
|---|---|---|---|
(n = 10) | (n = 11) | ||
Duration of MV, h | 44 [18–67] | 42 [19–37] | 0.62 |
Days until | |||
Discharge criteria fulfilled, days | 8 [7–8] | 9 [8–14] | 0.10 |
Target enteral nutrition, days | 5 [4–6] | 6 [5–8] | 0.09 |
Spontaneous defecation, days | 2 [1–2] | 2 [2–5] | 0.09 |